Targeting the ABCG2-overexpressing multidrug resistant (MDR) cancer cells by PPARγ agonists
出版年份 2013 全文链接
标题
Targeting the ABCG2-overexpressing multidrug resistant (MDR) cancer cells by PPARγ agonists
作者
关键词
-
出版物
BRITISH JOURNAL OF PHARMACOLOGY
Volume 170, Issue 5, Pages 1137-1151
出版商
Wiley
发表日期
2013-08-30
DOI
10.1111/bph.12367
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- PI3-kinase and mTOR inhibitors differently modulate the function of the ABCG2 multidrug transporter
- (2012) Csilla Hegedüs et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Inhibition of the PI3K-Akt signaling pathway disrupts ABCG2-rich extracellular vesicles and overcomes multidrug resistance in breast cancer cells
- (2012) Vicky Goler-Baron et al. BIOCHEMICAL PHARMACOLOGY
- Systemic Elevation of PTEN Induces a Tumor-Suppressive Metabolic State
- (2012) Isabel Garcia-Cao et al. CELL
- Targeting MDR in breast and lung cancer: Discriminating its potential importance from the failure of drug resistance reversal studies
- (2012) Laleh Amiri-Kordestani et al. DRUG RESISTANCE UPDATES
- Identification and characterization of the major alternative promoter regulating Bcrp1/Abcg2 expression in the mouse intestine
- (2011) Karthika Natarajan et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Bid as a potential target of apoptotic effects exerted by low doses of PPARγ and RXR ligands in breast cancer cells
- (2011) Daniela Bonofiglio et al. CELL CYCLE
- The controversial role of ABC transporters in clinical oncology
- (2011) Akina Tamaki et al. Essays in Biochemistry
- Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells
- (2011) Zhiyong Cheng et al. LEUKEMIA & LYMPHOMA
- Identification of a novel, tissue-specific ABCG2 promoter expressed in pediatric acute megakaryoblastic leukemia
- (2011) Patrick K. Campbell et al. LEUKEMIA RESEARCH
- Constitutive AhR activation leads to concomitant ABCG2-mediated multidrug resistance in cisplatin-resistant esophageal carcinoma cells
- (2011) Kenneth K.W. To et al. MOLECULAR CARCINOGENESIS
- ABCG2/BCRP Dysfunction as a Major Cause of Gout
- (2011) Hirotaka Matsuo et al. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
- Mutational Analysis of Threonine 402 Adjacent to the GXXXG Dimerization Motif in Transmembrane Segment 1 of ABCG2
- (2010) Orsolya Polgar et al. BIOCHEMISTRY
- Interaction of angiotensin receptor type 1 blockers with ATP-binding cassette transporters
- (2010) J. Weiss et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- The ABCG family of membrane-associated transporters: you don't have to be big to be mighty
- (2010) Ian D Kerr et al. BRITISH JOURNAL OF PHARMACOLOGY
- Design and Syntheses of Permethyl Ningalin B Analogues: Potent Multidrug Resistance (MDR) Reversal Agents of Cancer Cells
- (2010) Pu Yong Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- PTEN/PI3K/Akt Pathway Regulates the Side Population Phenotype and ABCG2 Activity in Glioma Tumor Stem-like Cells
- (2009) Anne-Marie Bleau et al. Cell Stem Cell
- Pleiotropic effects of telmisartan: still more to come?
- (2009) Ralf A Benndorf et al. JOURNAL OF HYPERTENSION
- Interaction of angiotensin II type 1 receptor blockers with P-gp substrates in Caco-2 cells and hMDR1-expressing membranes
- (2009) Emi Kamiyama et al. LIFE SCIENCES
- Analysis of ABCG2 expression and side population identifies intrinsic drug efflux in the HCC cell line MHCC-97L and its modulation by Akt signaling
- (2008) Chen Hu et al. CARCINOGENESIS
- Tenets of PTEN Tumor Suppression
- (2008) Leonardo Salmena et al. CELL
- Targeting the PI3K–AKT–mTOR pathway: progress, pitfalls, and promises
- (2008) Timothy A Yap et al. CURRENT OPINION IN PHARMACOLOGY
- Histone Modifications at the ABCG2 Promoter following Treatment with Histone Deacetylase Inhibitor Mirror Those in Multidrug-Resistant Cells
- (2008) K. K.W. To et al. MOLECULAR CANCER RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started